GTHX
G1 Therapeutics, Inc. Common Stock
GTHX
GTHX
Delisted
GTHX was delisted on the 17th of September, 2024.
80 hedge funds and large institutions have $38.6M invested in G1 Therapeutics, Inc. Common Stock in 2023 Q2 according to their latest regulatory filings, with 14 funds opening new positions, 18 increasing their positions, 29 reducing their positions, and 30 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
less funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
53% less first-time investments, than exits
New positions opened: 14 | Existing positions closed: 30
Holders
80
Holding in Top 10
–
Calls
$982K
Puts
$200K
Top Buyers
| 1 | +$662K | |
| 2 | +$522K | |
| 3 | +$465K | |
| 4 |
Renaissance Technologies
New York
|
+$321K |
| 5 |
BCM
Bridgeway Capital Management
Houston,
Texas
|
+$286K |
Top Sellers
| 1 | -$2.36M | |
| 2 | -$1.76M | |
| 3 | -$769K | |
| 4 |
Bank of America
Charlotte,
North Carolina
|
-$705K |
| 5 |
Millennium Management
New York
|
-$665K |